EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of F18-FDG PET/CT in the Evaluation of Pituitary Uptake

Adersh Stanly, Saumya Sara Sunny, Justin Benjamin, Hesarghatta Shyamasunde Asha, David Mathew, Junita Rachel John, Julie Hephzibah

World Journal of Nuclear Medicine · 01.12.2024 · 23 (04) · 234-241

DOI: 10.1055/s-0044-1787967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Nuclear Medicine, erschienen am 01.12.2024. Verfasst von Adersh Stanly und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pituitary adenoma is the most common disease that affects the gland and may be classified as functional/nonsecretory tumors. Inflammatory/infective causes may also affect the pituitary gland. The 18F-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) may have an incremental value in assessing these lesions and in determining their clinical significance.

Aim

This article assesses the utility of F18-FDG PET/CT in detecting and determining clinical profile of pituitary lesions with abnormal uptake. Methodology Retrospective analysis of all patients who underwent F18-FDG PET/CT from January 2015 to January 2023 was done. Those with abnormal pituitary uptake (standardized uptake value [SUV] > 2.5) were included in the study. SUV value along with relevant anatomical details, biochemical parameters, histopathological details, and follow-up imaging were analyzed.

Results

Among 15,085 studies, a total of 36 patients (21 males/15 females, average age 47.36 years, range: 17–75 years) with pituitary uptake (0.23%) were included. Out of 36 patients, causes are primary pituitary tumor (21/36, 58%), tubercular hypophysitis (3/36, 8%), lymphocytic hypophysitis (2/36, 6%), lymphomatous involvement (2/36, 6%), autoimmune hypophysitis (1/36, 3%), questionable significance/incidental (4/36, 11%), and metastasis (3/36, 8%)—one each from neuroendocrine tumor ileum, chondrosarcoma, and adenocarcinoma lung. There was no difference in the SUV range between the different etiologies. Among 21 patients with pituitary tumor, biochemical evaluation was done in 19 patients. Two patients were lost to follow-up and did not have biochemical evaluation. Among them, 8 underwent endoscopic transsphenoidal radical excision and 1 patient had PET-CT-guided stereotactic radiosurgery alone. In another 8 patients who had prior endoscopic transsphenoidal radical excision, uptake was noted as residual lesion on PET-CT. Of them, 3 underwent subtotal excision and 5 had PET-CT-guided stereotactic radiosurgery. Biopsy was done in 14 patients, of which 11 were macroadenoma and 3 were microadenoma. Overall, magnetic resonance imaging (MRI) brain was performed in 22 of them and the findings were concordant with F18-FDG PET/CT.

Conclusion

F18-FDG PET/CT is a useful modality in the evaluation of pituitary uptake. It has an incremental value along with MRI brain and biochemical parameters and is useful for follow-up. Due to its high diagnostic accuracy, it is particularly useful in those with suspected residual/recurrent adenomas.

Schlagwörter

Stichwörter der Autor:innen

F18-FDG PET/CThypophysitismacroadenomapituitary adenomapituitary uptake

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
  • Department of Endocrinology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.

Zitieren

APA

Stanly, A., Sunny, S. S., Benjamin, J., Asha, H. S., Mathew, D., John, J. R., & Hephzibah, J. (2024). Utility of F18-FDG PET/CT in the Evaluation of Pituitary Uptake. World Journal of Nuclear Medicine, 23(04), 234-241. https://doi.org/10.1055/s-0044-1787967

Vancouver

Stanly A, Sunny SS, Benjamin J, Asha HS, Mathew D, John JR, et al. Utility of F18-FDG PET/CT in the Evaluation of Pituitary Uptake. World Journal of Nuclear Medicine. 2024;23(04):234-241. doi:10.1055/s-0044-1787967

BibTeX
@article{Stanly2024,
  author = {Stanly, Adersh and Sunny, Saumya Sara and Benjamin, Justin and Asha, Hesarghatta Shyamasunde and Mathew, David and John, Junita Rachel and Hephzibah, Julie},
  title = {Utility of F18-FDG PET/CT in the Evaluation of Pituitary Uptake},
  journal = {World Journal of Nuclear Medicine},
  year = {2024},
  volume = {23},
  number = {04},
  pages = {234--241},
  doi = {10.1055/s-0044-1787967}
}
Kostenlos starten →